Pre-Series B · Biotech
Forlong Biotechnology: Pre-Series B
Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer
Funding history
Pre-Series B · This round$17.5M
Loading rounds…
Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer